Outset Medical OM
NASDAQ OM
$3.22 -0.09 (-2.71%)
As of: Sep 10, 2026 · 3:40 PM EDT

Outset Medical (OM) Gains from Investment Securities (2025)

Outset Medical's (OM) quarterly Gains from Investment Securities came in at $4.4 million in Q1 2025.

Analysis

Outset Medical (OM) Gains from Investment Securities (2025) Analysis & Trends

Outset Medical (OM) has reported Gains from Investment Securities for 1 consecutive years, with $4.4 million the latest figure, recorded in Q1 2025.

  • On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to $4.4 million in Q1 2025; TTM through Dec 2025 was $4.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $4.4 million, changed N/A from the prior year.
  • Gains from Investment Securities was $4.4 million for Q1 2025 at Outset Medical.
  • Over five years, Gains from Investment Securities peaked at $4.4 million in Q1 2025 and troughed at $4.4 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 180.05 Bn 174.44 Bn 7.27 Bn
2 Intuitive Surgical 127.97 Bn 122.75 Bn 1.96 Bn
3 Medtronic 117.27 Bn 108.45 Bn 6.34 Bn
4 Stryker 103.98 Bn 100.50 Bn 4.50 Bn
5 Boston Scientific 63.03 Bn 62.49 Bn 3.85 Bn
6 Edwards Lifesciences 49.83 Bn 45.58 Bn 1.35 Bn
7 Alcon 32.93 Bn 31.47 Bn 1.68 Bn
8 Dexcom 32.26 Bn 30.31 Bn 830.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn
10 Outset Medical 59.95 Mn -203.24 Mn 13.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 4.37 Mn